Country websites

Company profile

We are the leading provider of products and services for individuals with renal diseases.

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases of which around 4.1 million patients worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. We care for more than 332,000 patients in our global network of roughly 4,000 dialysis clinics. At the same time, we operate around 40 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
 
Fresenius Medical Care aims to further consolidate its expertise and to use this competence as a basis for sustainable, profitable growth. We aim to continuously improve our patients’ quality of life by offering them high-quality products as well as innovative technologies and treatment concepts.
 
Fresenius Medical Care’s corporate headquarters is in Bad Homburg v. d. Höhe, Germany. The headquarters in North America is in Waltham, Massachusetts, the headquarters of Asia-Pacific is located in Hongkong and the headquarters of Latin America is in Rio de Janeiro

Our history

1462
1951
1966
2003
2007
2013
2014
2016
2018
2019
2020
/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_1912_e09f9fd0e3.jpg

1462

Foundation of the Hirsch Pharmacy is established in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_1951_2e8586ce83.jpg

1951

Else Fernau, later Else Kröner, takes over the responsibility for the pharmacy and the company after obtaining her pharmacy degree.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_1966_66cfe6d46c.jpg

1966

Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_2003_802e833016.jpg

2003

Fresenius Medical Care is the leading dialysis company, caring, for more than 119,000 patients in its own dialysis centres worldwide. With a production output of more than 50 million dialyzers per year, Fresenius Medical Care sets a new record.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_2007_7d0c9e88cd.jpg

2007

Fresenius Medical Care continues its success as the leading manufacturer of dialyzers, producing its 500 millionth dialyzer.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_2013_6898f8685b.jpg

2013

Fresenius Medical Care produces its billionth dialyzer.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2014.jpg

2014

A new generation of home dialysis cyclers is launched – sleep•safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy.

/content/dam/fresenius-medical-care/hungary/images/betegek-és-családtagjaik/csm_2016_f1576f575b.jpg

2016

Launch of the 6008 CAREsystem, a new hemodialysis therapy system, that delivers advanced dialysis therapy more easily, leaving more time for direct patient care.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2018.jpg

2018

Fresenius Medical Care launches the 4008A dialysis machine tailored to needs in emerging markets.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2019.jpg

2019

By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home dialysis offering patients greater flexibility.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2020.jpg

2020

Launch of the Global Sustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years. Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth.

Fresenius Medical Care in numbers (Full Year 2023)

  • Through our network of around 4,000 dialysis clinics, we provide dialysis treatments to more than 332,000 patients worldwide.
  • We offer dialysis products in around 150 countries.
  • We performed around 52 million dialysis treatments in 2023.
  • Around 120,000 employees work for Fresenius Medical Care worldwide.
  • We are the market leader in the production of hemodialysis machines.
  • We operate around 40 production sites in around 20 countries.
  • In 2023, Fresenius Medical Care generated revenue of around 19.45 billion euros.

Major locations

Research and development

Developing innovative products and continuously improving our renal therapies are intrinsic elements of our growth strategy.

Our worldwide research and development activities, which are centrally managed by the Global Research and Development division (GRD), enable us to develop products and renal therapies efficiently and to systematically promote the exchange of knowledge and technology between regions.

Corporate culture

We strive to create a future worth living for dialysis patients. Worldwide. Everyday.

  • Collaborating
  • proactiveness 
  • Reliability
  • Excellence
     

To learn more about our Corporate culture and mission, visit our Global Website.

Sustainability

For us, sustainability means environmental and social progress as well as responsible action to achieve success at work.

  • We assume economic responsibility
  • We take responsibility for the environment
  • We assume social responsibility
     

To get more information about our responsibility, have a look at our Global Website.

Compliance

As the market leader worldwide, Fresenius Medical Care is aware of its responsibility and takes it seriously. With our rules and company ethics we want to set standards that comply with our own and our stakeholders’ expectations.

Fresenius Medical Care is committed to conduct its business activities in compliance with local laws and regulations that apply to our business. We seek to demonstrate professionalism, honesty and integrity in our business relationships with patients, customers, suppliers, the government and other payors, fellow employees, investors and the general public.

Additionally Fresenius Medical Care has implemented business ethics and principles for business partners which outline the principles for all third parties acting on behalf of Fresenius Medical Care. The emphasis is on environmentally sound and resource-efficient production as well as fair and humane working conditions at our suppliers.

To learn more about compliance at Fresenius Medical Care, visit our Global Website.

More information 

For more information see the Downloads section on: 

Fresenius Medical Care Company Profile (Global website)

Do not hesitate to contact us for further information

Related content